These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37491519)

  • 21. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
    BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
    Böckenhauer J; Schild R; Kemper MJ; Henne T; Stein MV; Oh J; Loos S
    Pediatr Nephrol; 2024 Jun; 39(6):1901-1907. PubMed ID: 38240870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.
    Wijnsma KL; Schijvens AM; Rossen JWA; Kooistra-Smid AMDM; Schreuder MF; van de Kar NCAJ
    Pediatr Nephrol; 2017 Jul; 32(7):1263-1268. PubMed ID: 28343354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?
    Mauras M; Bacchetta J; Duncan A; Lavocat MP; Rohmer B; Javouhey E; Collardeau-Frachon S; Sellier-Leclerc AL
    Pediatr Nephrol; 2019 Jul; 34(7):1289-1293. PubMed ID: 30963282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constipation and hemolytic uremic syndrome.
    Crawford B; Strebeck P; Saccente S
    Pediatr Nephrol; 2024 Feb; 39(2):603-607. PubMed ID: 37474629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S; Aulbert W; Hoppe B; Ahlenstiel-Grunow T; Kranz B; Wahl C; Staude H; Humberg A; Benz K; Krause M; Pohl M; Liebau MC; Schild R; Lemke J; Beringer O; Müller D; Härtel C; Wigger M; Vester U; Konrad M; Haffner D; Pape L; Oh J; Kemper MJ
    Clin Infect Dis; 2017 Jun; 64(12):1637-1643. PubMed ID: 28329394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
    Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Myocarditis and Eculizumab Caused Severe Cholestasis in a 17-Month-Old Child Who Has Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing
    Yesilbas O; Yozgat CY; Akinci N; Sonmez S; Tekin E; Talebazadeh F; Jafarov U; Temur HO; Yozgat Y
    J Pediatr Intensive Care; 2021 Sep; 10(3):216-220. PubMed ID: 34395040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
    Peco-Antić A
    Srp Arh Celok Lek; 2016; 144(11-12):664-9. PubMed ID: 29659236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and neurological involvement in typical Shiga toxin-associated HUS.
    Trachtman H; Austin C; Lewinski M; Stahl RA
    Nat Rev Nephrol; 2012 Nov; 8(11):658-69. PubMed ID: 22986362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
    Loirat C
    Rev Prat; 2013 Jan; 63(1):11-6. PubMed ID: 23457821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Province-Wide Review of Pediatric Shiga Toxin-Producing Escherichia coli Case Management.
    Freedman SB; Eltorki M; Chui L; Xie J; Feng S; MacDonald J; Dixon A; Ali S; Louie M; Lee BE; Osterreicher L; Thull-Freedman J
    J Pediatr; 2017 Jan; 180():184-190.e1. PubMed ID: 27745751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
    Trials; 2023 May; 24(1):359. PubMed ID: 37245030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.